Skadden, Arps, Slate, Meagher & Flom advised New York Community Bancorp on the transaction, Kirkland & Ellis counseled Reverence Capital Partners, Latham & Watkins represented Jefferies...
New York Community Bancorp’s $1 Billion Equity Investment
Gates Industrial’s $246 Million Ordinary Shares Offering
Simpson Thacher & Bartlett advised Gates Industrial Corporation plc on the offering, and Davis Polk & Wardwell advised the representatives of the underwriters. Gates Industrial Corporation...
Prime Medicine’s $161.0 Million Common Stock Offering
Goodwin Procter advised Prime Medicine and Wilson Sonsini Goodrich & Rosati advised Prime Medicine on IP matters related to the transaction, while Davis Polk & Wardwell...
Immunocore Holdings’ $402.5 Million Convertible Notes Offering
Davis Polk & Wardwell advised the several initial purchasers on the offering. Immunocore Holdings plc (Immunocore) (Nasdaq: IMCR) announced the pricing of $350.0 million aggregate principal amount...
Astria Therapeutics’ $125 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr advised Astria Therapeutics, Inc., and Cooley advised the underwriters. Astria Therapeutics, Inc. (Astria) (Nasdaq: ATXS) announced it completed its underwritten registered...
IDEAYA Biosciences’ $350 Million At-the-Market Offering
Latham & Watkins advised IDEAYA Biosciences, Inc. on the offering, and Davis Polk & Wardwell advised Jefferies LLC, as sales agent. IDEAYA Biosciences, Inc. (NYSE: IDYA)...
AC Immune SA’s $50 Million Common Shares Offer
Homburger advised Jefferies LLC and Leerink Partners LLC on the deal. AC Immune SA, a Swiss clinical stage biopharmaceutical company pioneering in precision medicine for neurodegenerative...
Gates Industrial’s $194 Million Ordinary Shares Offering
Simpson Thacher & Bartlett advised Gates Industrial Corporation plc on the offering, and Davis Polk & Wardwell advised the representative of the underwriters. Gates Industrial Corporation...
Celldex Therapeutics’ $230.5 Million Common Stock Offering
Lowenstein Sandler advised Celldex Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters. Celldex Therapeutics, Inc. (Nasdaq: CLDX) (“Celldex”) announced the...
CARGO Therapeutics’ $281.3 Million Initial Public Offering
Wilson Sonsini Goodrich & Rosati and Latham & Watkins advised CARGO Therapeutics, Inc. on the offering, and Cooley advised the underwriters. CARGO Therapeutics, Inc. (CARGO) (Nasdaq:CRGX)...
IDEAYA Biosciences’ $143.8 Million Common Stock Offering
Latham & Watkins advised IDEAYA Biosciences, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the several underwriters. IDEAYA Biosciences, Inc. (NASDAQ:IDYA)...
CSG Systems International’s $425 Million Convertible Senior Notes Offering
Simpson Thacher & Bartlett advised CSG Systems International, Inc., and Davis Polk & Wardwell advised the representatives of the initial purchasers on the offering. CSG Systems...